Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-reductase inhibitors: Preventing the treatable. Eur Urol 2012;62:242-4

J. Kellogg Parsons; Jeannette M. Schenk; Kathryn B. Arnold; Karen Messer; Cathee Till; Ian M. Thompson; Alan R. Kristal

doi:10.1016/j.eururo.2012.05.004

Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-reductase inhibitors: Preventing the treatable. Eur Urol 2012;62:242-4

J. Kellogg Parsons, Jeannette M. Schenk, Kathryn B. Arnold, Karen Messer, Cathee Till, Ian M. Thompson, Alan R. Kristal

Mays Cancer Center

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	244-245
Number of pages	2
Journal	European Urology
Volume	62
Issue number	2
DOIs	https://doi.org/10.1016/j.eururo.2012.05.004
State	Published - Aug 2012

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2012.05.004

Cite this

Reply from Authors re : Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-reductase inhibitors: Preventing the treatable. Eur Urol 2012;62:242-4. / Parsons, J. Kellogg; Schenk, Jeannette M.; Arnold, Kathryn B.; Messer, Karen; Till, Cathee; Thompson, Ian M.; Kristal, Alan R.

In: European Urology, Vol. 62, No. 2, 08.2012, p. 244-245.

Research output: Contribution to journal › Editorial › peer-review

@article{af5e3564ccad43a8b441cab885d8c3f6,

title = "Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-reductase inhibitors: Preventing the treatable. Eur Urol 2012;62:242-4",

author = "Parsons, {J. Kellogg} and Schenk, {Jeannette M.} and Arnold, {Kathryn B.} and Karen Messer and Cathee Till and Thompson, {Ian M.} and Kristal, {Alan R.}",

year = "2012",

month = aug,

doi = "10.1016/j.eururo.2012.05.004",

language = "English (US)",

volume = "62",

pages = "244--245",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Reply from Authors re

T2 - Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-reductase inhibitors: Preventing the treatable. Eur Urol 2012;62:242-4

AU - Parsons, J. Kellogg

AU - Schenk, Jeannette M.

AU - Arnold, Kathryn B.

AU - Messer, Karen

AU - Till, Cathee

AU - Thompson, Ian M.

AU - Kristal, Alan R.

PY - 2012/8

Y1 - 2012/8

UR - http://www.scopus.com/inward/record.url?scp=84862903484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862903484&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2012.05.004

DO - 10.1016/j.eururo.2012.05.004

M3 - Editorial

AN - SCOPUS:84862903484

VL - 62

SP - 244

EP - 245

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 2

ER -

Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-reductase inhibitors: Preventing the treatable. Eur Urol 2012;62:242-4

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this